BMC Cancer

official impact factor 3.15

Open Access Highly Access Email this article to a friend

Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report

Martin F Sprinzl*, Carl C Schimanski, Markus Moehler, Simin Schadmand-Fischer, Peter R Galle and Stephan Kanzler

BMC Cancer 2006, 6:190 doi:10.1186/1471-2407-6-190

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.